Med Princ Pract. 2018;27(5):459-465. doi: 10.1159/000489399. Epub 2018 Apr 19.
We evaluated the relationship between various risk scores (SYNTAX score [SS], SYNTAX score-II [SS-II], thrombolysis in myocardial infarction [TIMI] risk scores, and Global Registry of Acute Coronary Events [GRACE] risk scores) and major adverse cardiovascular events (MACE) in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI).
The study population were selected from among 589 patients who underwent coronary angiography with a diagnosis of NSTEMI. TIMI and GRACE risk scores were calculated. SS and SS-II were calculated in all patients, and points were added according to the predefined algorithm, taking into account the other 6 clinical variables being monitored (age, sex, left ventricular ejection fraction, creatinine clearance, chronic obstructive pulmonary disease, and peripheral artery disease). Patients were classified into tertile 1 (SS < 22), tertile 2 (SS 23-32), and tertile 3 (SS > 32).
The group with high SS-II for PCI values in the risk scores were observed from tertile 1 to tertile 3 (from 25.0 ± 7.7 to 31.6 ± 9.4, p < 0.001, respectively). The SS-II score in patients with PCI was an independent predictor of MACE, in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis (OR 1.082, 95% CI 1.036-1.131, p < 0.001). The overall MACE, in-hospital mortality, and nonfatal myocardial infarction rates were significantly higher in the high SS-II for PCI group (p < 0.001).
TIMI and GRACE risk scores were able to predict MACE. In addition to these, SS-II was also able to predict in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis.
我们评估了不同风险评分(SYNTAX 评分[SS]、SYNTAX 评分-II[SS-II]、心肌梗死溶栓治疗[TIMI]风险评分和全球急性冠状动脉事件注册[GRACE]风险评分)与非 ST 段抬高型心肌梗死(NSTEMI)患者行经皮冠状动脉介入治疗(PCI)后主要不良心血管事件(MACE)之间的关系。
研究人群选自 589 例行冠状动脉造影诊断为 NSTEMI 的患者。计算 TIMI 和 GRACE 风险评分。对所有患者计算 SS 和 SS-II,并根据预定义的算法根据其他 6 个监测的临床变量(年龄、性别、左心室射血分数、肌酐清除率、慢性阻塞性肺疾病和外周动脉疾病)添加积分。患者分为 3 个三分位 1(SS<22)、三分位 2(SS23-32)和三分位 3(SS>32)。
观察到风险评分中 PCI 值的 SS-II 较高的患者从三分位 1 到三分位 3(分别为 25.0±7.7 至 31.6±9.4,p<0.001)。PCI 患者的 SS-II 评分是 MACE、住院死亡率、非致死性心肌梗死和支架血栓形成的独立预测因素(OR 1.082,95%CI 1.036-1.131,p<0.001)。高 SS-II 组的总体 MACE、住院死亡率和非致死性心肌梗死发生率显著更高(p<0.001)。
TIMI 和 GRACE 风险评分能够预测 MACE。除了这些评分,SS-II 还能够预测住院死亡率、非致死性心肌梗死和支架血栓形成。